The Disease Forecasting Company.
New analysis was presented live at the Copenhagen Democracy Summit by Airfinity’s CEO and founder Rasmus Bech Hansen.
Read More →
From resistance to resilience: what could the future antibiotic pipeline look like?
Airfinity further expands into APAC with launch of Japan office
Stockpiles worth $1.1 billion of COVID-19 antiviral pill Paxlovid have expired in UK and Europe
Airfinity Named The Financial Times' Healthcare Tech Champion 2023
Airfinity upgrades global biorisk platform
Airfinity named among Bloomberg’s UK Startups to Watch 2023
France faces massive increase in dengue cases by 2030
View All →
Democracies are better at managing pandemics than autocracies, according to a new study by Airfinity
AP News | May 15, 2024
The Missing Factor In Explanations Of China’s Economic Distress: COVID – Part 2: Estimating The True Death Toll
Forbes | May 12, 2024
The truth about AstraZeneca’s Covid vaccine
Independent | May 8, 2024
The terrifying 100-day cough sweeping Britain: Cases are up 3,800 percent with young babies at risk
Daily Mail | May 6, 2024
View All →
What's happening in a given disease area?
Airfinity is the most comprehensive, single source of intelligence for new developments in your chosen area.
Identify the true need for a vaccine or a treatment.
Our suite of dynamic predictive indicators help you navigate highly dynamic and uncertain market developments and see the real opportunities.
Maximise impact to save lives
Our analytics and probabilistic tools inform key decisions on resource allocation, investment and procurement decisions to maximise impact of a given drug or vaccine and ultimately improve as many lives as possible.
Airfinity develops and deploys dynamic disease forecasting models to support horizon scanning, medical countermeasure impact modelling, clinical trial site optimisation, scenario-based demand intelligence, portfolio optimisation and more.
“The Airfinity report is a guide for world leaders to fix a more ambitious action plan.”
Gordon Brown, WHO Ambassador for Global Health Financing & former UK Prime Minister
“Airfinity has been instrumental in our country's COVID response.”
Head of UK Government
Vaccine Task Force
In a dynamic environment, Airfinity enabled us to remain on track with daily developments to enable more accurate decision-making. Airfinity combines nimbleness of real time data and their group of scientists that can analyse, model and provide strategic analysis for critical decision making.”
Iskra Reic, Executive Vice-President
Astrazeneca
“Probably the most expansive, accurate and helpful of the multiple data sets on an international scale”
Sir John Bell ,
University of Oxford